fda glp-1 compounding warning letters october 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA alerts health care providers,

Originally developed for medical purposes, different formulations of Sermorelin were approved by the FDA in 1990 and 1997 for the treatment of growth hormone deficiency in children

Some patients successfully maintain weight loss without medication, but only if they achieve durable changes in eating behavior and physical activity

Because your body can store B12 for 2 to 5 years, a serious B12 deficiency is rare

Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial

Continued awareness and ongoing public education about the risks of acetaminophen toxicity aim at further minimizing this hazard and increasing the medications safety profile ( Sidebar )